321053- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V (SGB V) through an open-house model for the active ingredient ustekinumab (ATC code according to WHO: L04AC05)

World Biggest Tenders Source

This tender with title 321053- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V (SGB V) through an open-house model for the active ingredient ustekinumab (ATC code according to WHO: L04AC05) has been published on Bidding Source portal dated 20 May 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

321053- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V (SGB V) through an open-house model for the active ingredient ustekinumab (ATC code according to WHO: L04AC05)

Tender Type :

Invitation for Bids

Reference No. :

321053

Country :

Germany

Publish Date :

20 May 2025

Closing Date :

31 Jul 2026

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

321919- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient denosumab, trade name Prolia, ATC M05BX04 Germany 321743- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient peginterferon alfa-2a, ATC L03AB11 Germany 320391- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient denosumab, trade name Xgeva, ATC M05BX04 Germany 320283- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient Risankizumab, ATC L04AC18 Germany 319216- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient Bimekizumab, ATC L04AC21 Germany 318670- Germany – Pharmaceutical products – Medicines containing the active ingredient Axitinib (ATC: L01EK01) Germany 318604- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient Axitinib, ATC L01EK01 Germany 322201- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the option of concluding the agreement within the framework of the so-called open house procedure. Germany 315373- Germany – Pharmaceutical products – Open house drug discount contracts Ticagrelor, ATC B01AC24 Germany 307018- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for medicinal products containing the active ingredient octreotide, in a dosage form with delayed release (ATC Code: H01CB02). Germany

321053- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V (SGB V) through an open-house model for the active ingredient ustekinumab (ATC code according to WHO: L04AC05)

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com